Stringent drug regulation: Regulation and control of the importation, exportation, manufacture, advertisement, distribution, sale and the use of medicines, cosmetics, medical devices and chemicals

The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has
had a positive result on government deficit. The investment law approved recently has good statements and rules on
the above strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the
government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public
pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health
conditions. Medicines are financed either through cost sharing or full private. The role of the private services is
significant. A review of reform of financing medicines in Sudan is given in this article. Also, it highlights the
current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies
Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative
studies about the impact of drug regulations on the quality of medicines and how to protect public health against
counterfeit or low quality medicines, although it is practically possible. However, the regulations must be
continually evaluated to ensure the public health is protected against by marketing high quality medicines rather
than commercial interests, and the drug companies are held accountable for their conducts.